{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T01:58:30Z","timestamp":1773799110861,"version":"3.50.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.jad.2011.11.043","type":"journal-article","created":{"date-parts":[[2011,12,31]],"date-time":"2011-12-31T00:57:40Z","timestamp":1325293060000},"page":"258-266","source":"Crossref","is-referenced-by-count":22,"title":["A 40-week double-blind aripiprazole versus lithium follow-up of a 12-week acute phase study (total 52weeks) in bipolar I disorder"],"prefix":"10.1016","volume":"136","author":[{"given":"Rif S.","family":"El-Mallakh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Marcus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Baudelet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"McQuade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William H.","family":"Carson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randall","family":"Owen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2011.11.043_bb0190","series-title":"Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR Fourth Edition","author":"APA","year":"2000"},{"issue":"4 Suppl.","key":"10.1016\/j.jad.2011.11.043_bb0195","first-page":"1","article-title":"Practice guideline for the treatment of patients with bipolar disorder (revision)","volume":"159","author":"APA","year":"2002","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.jad.2011.11.043_bb0015","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A rating scale for drug-induced akathisia","volume":"154","author":"Barnes","year":"1989","journal-title":"The British Journal of Psychiatry"},{"issue":"5","key":"10.1016\/j.jad.2011.11.043_bb0020","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1177\/0269881108093885","article-title":"Pharmacological interventions for the prevention of relapse in bipolar disorder: a systematic review of controlled trials","volume":"23","author":"Beynon","year":"2009","journal-title":"Journal of Psychopharmacology"},{"issue":"4","key":"10.1016\/j.jad.2011.11.043_bb0025","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1001\/archpsyc.60.4.392","article-title":"A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder","volume":"60","author":"Bowden","year":"2003","journal-title":"Archives of General Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2011.11.043_bb0030","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1124\/jpet.102.033175","article-title":"Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors","volume":"302","author":"Burris","year":"2002","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"9","key":"10.1016\/j.jad.2011.11.043_bb0035","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.4088\/JCP.v64n0906","article-title":"A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder","volume":"64","author":"Calabrese","year":"2003","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2011.11.043_bb0040","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00213-006-0564-3","article-title":"Effectiveness of long-term aripiprazole therapy in patients with acutely relapsing or chronic, stable schizophrenia: a 52-week, open-label comparison with olanzapine","volume":"189","author":"Chrzanowski","year":"2006","journal-title":"Psychopharmacology"},{"issue":"11","key":"10.1016\/j.jad.2011.11.043_bb0045","doi-asserted-by":"crossref","first-page":"470","DOI":"10.4088\/JCP.v58n1102","article-title":"Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder","volume":"58","author":"Denicoff","year":"1997","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"6","key":"10.1016\/j.jad.2011.11.043_bb0050","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.biopsych.2008.07.033","article-title":"A double-blind, randomized comparative study of aripiprazole and olanzapine in patients with schizophrenia","volume":"65","author":"Fleischhacker","year":"2009","journal-title":"Biological Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2011.11.043_bb0055","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0165-0327(96)01427-9","article-title":"Lithium versus carbamazepine in the maintenance treatment of bipolar disorders\u2014a randomised study","volume":"43","author":"Greil","year":"1997","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.jad.2011.11.043_bb0060","series-title":"ECDEU Assessment Manual for Psychopharmacology US Department of Health, Education, and Welfare publication (ADM) 76\u2013338","first-page":"534","article-title":"Abnormal Involuntary Movement Scale (AIMS)","author":"Guy","year":"1976"},{"issue":"3","key":"10.1016\/j.jad.2011.11.043_bb0065","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0014-2999(02)01532-7","article-title":"The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT(1A) receptor","volume":"441","author":"Jordan","year":"2002","journal-title":"European Journal of Pharmacology"},{"issue":"1","key":"10.1016\/j.jad.2011.11.043_bb0070","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejphar.2003.10.025","article-title":"In vivo effects of aripiprazole on cortical and striatal dopaminergic and serotonergic function","volume":"483","author":"Jordan","year":"2004","journal-title":"European Journal of Pharmacology"},{"issue":"9","key":"10.1016\/j.jad.2011.11.043_bb0075","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1001\/archpsyc.1982.04290090053011","article-title":"Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness: a prospective, placebo-controlled comparison","volume":"39","author":"Kane","year":"1982","journal-title":"Archives of General Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2011.11.043_bb0080","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1017\/S1461145703003651","article-title":"Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia","volume":"6","author":"Kasper","year":"2003","journal-title":"The International Journal of Neuropsychopharmacology"},{"issue":"12","key":"10.1016\/j.jad.2011.11.043_bb0100","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.4088\/JCP.v64n1205","article-title":"Bipolar disorder, obesity, and pharmacotherapy-associated weight gain","volume":"64","author":"Keck","year":"2003","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"9","key":"10.1016\/j.jad.2011.11.043_bb0095","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1176\/appi.ajp.160.9.1651","article-title":"A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania","volume":"160","author":"Keck","year":"2003","journal-title":"The American Journal of Psychiatry"},{"issue":"4","key":"10.1016\/j.jad.2011.11.043_bb0090","doi-asserted-by":"crossref","first-page":"626","DOI":"10.4088\/JCP.v67n0414","article-title":"A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder","volume":"67","author":"Keck","year":"2006","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"10","key":"10.1016\/j.jad.2011.11.043_bb0085","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.4088\/JCP.v68n1003","article-title":"Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo","volume":"68","author":"Keck","year":"2007","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"1\u20133","key":"10.1016\/j.jad.2011.11.043_bb0105","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jad.2008.05.014","article-title":"Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study","volume":"112","author":"Keck","year":"2009","journal-title":"Journal of Affective Disorders"},{"key":"10.1016\/j.jad.2011.11.043_bb0110","article-title":"A 52-week, double-blind evaluation of the metabolic effects of aripiprazole and lithium in bipolar I disorder","volume":"13","author":"McIntyre","year":"2011","journal-title":"The Primary Care Companion for CNS Disorders"},{"key":"10.1016\/j.jad.2011.11.043_bb0115","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"The British Journal of Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2011.11.043_bb0120","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archpsyc.1973.01750330035006","article-title":"Prophylactic efficacy of lithium carbonate in manic-depressive illness. Report of the Veterans Administration and National Institute of Mental Health collaborative study group","volume":"28","author":"Prien","year":"1973","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2011.11.043_bb0125","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000209348","article-title":"Does study design influence outcome? The effects of placebo control and treatment duration in antidepressant trials","volume":"78","author":"Rutherford","year":"2009","journal-title":"Psychotherapy and Psychosomatics"},{"issue":"2","key":"10.1016\/j.jad.2011.11.043_bb0130","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1399-5618.2006.00308.x","article-title":"Effects of lamotrigine and lithium on body weight during maintenance treatment of bipolar I disorder","volume":"8","author":"Sachs","year":"2006","journal-title":"Bipolar Disorders"},{"issue":"4","key":"10.1016\/j.jad.2011.11.043_bb0135","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1177\/0269881106059693","article-title":"Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study","volume":"20","author":"Sachs","year":"2006","journal-title":"Journal of Psychopharmacology"},{"issue":"8","key":"10.1016\/j.jad.2011.11.043_bb0140","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/sj.npp.1300203","article-title":"Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology","volume":"28","author":"Shapiro","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2011.11.043_bb0145","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatrica Scandinavica. Supplementum"},{"issue":"3","key":"10.1016\/j.jad.2011.11.043_bb0150","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00213-006-0621-y","article-title":"Interaction of the novel antipsychotic aripiprazole with 5-HT(1A) and 5-HT (2A) receptors: functional receptor-binding and in vivo electrophysiological studies","volume":"190","author":"Stark","year":"2007","journal-title":"Psychopharmacology"},{"issue":"7","key":"10.1016\/j.jad.2011.11.043_bb0155","doi-asserted-by":"crossref","first-page":"870","DOI":"10.4088\/JCP.v66n0710","article-title":"The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar I disorder","volume":"66","author":"Suppes","year":"2005","journal-title":"The Journal of Clinical Psychiatry"},{"issue":"9","key":"10.1016\/j.jad.2011.11.043_bb0160","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.2174\/138945006778226598","article-title":"Antipsychotic medications in the treatment of bipolar disorder","volume":"7","author":"Surja","year":"2006","journal-title":"Current Drug Targets"},{"issue":"7","key":"10.1016\/j.jad.2011.11.043_bb0165","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1176\/appi.ajp.162.7.1281","article-title":"Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial","volume":"162","author":"Tohen","year":"2005","journal-title":"The American Journal of Psychiatry"},{"issue":"6","key":"10.1016\/j.jad.2011.11.043_bb0175","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s11920-005-0066-8","article-title":"Evidence-based research on the efficacy of psychologic interventions in bipolar disorders: a critical review","volume":"7","author":"Vieta","year":"2005","journal-title":"Current Psychiatry Reports"},{"issue":"8","key":"10.1016\/j.jad.2011.11.043_bb0170","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1017\/S1461145711000885","article-title":"Effectiveness of psychotropic medications in the maintenance phase of bipolar disorder: a meta-analysis of randomized controlled trials","volume":"14","author":"Vieta","year":"2011","journal-title":"The International Journal of Neuropsychopharmacology"},{"key":"10.1016\/j.jad.2011.11.043_bb0185","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"The British Journal of Psychiatry"},{"issue":"1","key":"10.1016\/j.jad.2011.11.043_bb0180","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1192\/bjp.bp.108.049965","article-title":"Aripiprazole monotherapy in acute mania: 12-week randomised placebo- and haloperidol-controlled study","volume":"194","author":"Young","year":"2009","journal-title":"The British Journal of Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032711007609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032711007609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,27]],"date-time":"2018-11-27T05:53:37Z","timestamp":1543298017000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032711007609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0165032711007609"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2011.11.043","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}